|
Fei-Fei’s broad practice covers all phases of representation before the US Patent and Trademark Office and other intellectual property related matters, including, but not limited to, technology licensing; opinion; due diligence and patent portfolio design; and intellectual property litigation. In patent prosecution, Fei-Fei’s broad practice covers biotechnology, pharmaceuticals, cosmetics, natural products, electronics and mechanical art. She is particularly well known for her successful representation of clients in the field of traditional Chinese herbal medicines. In intellectual property litigation, Fei-Fei has represented clients in trade secret, trademark and patent infringement litigation in various courts (including appellate courts and before the International Trade Commission (ITC)) in the United States. She is particularly known for her successful representation of clients in litigation at the ITC under Section 337 of the Tariff Act of 1930 and involving Abbreviated New Drug Application (ANDA) and FDA matters. Her litigation experience covers a variety of technologies, including, but not limited to, biotechnology, pharmaceuticals, electronics, power supplies, LCD televisions and monitors, integrated circuit designs, computer software, and batteries.
Fei-Fei holds a doctorate in biochemistry, and has seven years of research and teaching experience.
REPRESENTATIVE EXPERIENCE
Meridian Diagnostic Inc. v. Apollo Biotechnology Co. (Federal District Court for the District of Ohio at Cincinnati). Represented Apollo Biotechnology against Meridian Diagnostic Inc. for trade secret misappropriation and violation of non-competition agreement. (2000)
Bayer Pharmaceutical Co. v. Carlsbad Technology Inc. (Federal District Court for the Southern District of California at San Diego). Represented Carlsbad Technology Inc. against Bayer for patent infringement, which involved Bayer’s blockbuster drug Ciprofloxacin. (2001-2002)
Eli Lilly Pharmaceutical Co. v. Carlsbad Technology Inc. (Federal District Court for the District of Illinois at Indianapolis). Represented Carlsbad Technology Inc. against Eli Lilly for patent infringement, which involved Eli Lilly’s blockbuster drug Prozac. (2002-2003)
Richter Gideon Pharmaceutical Co. v. Carlsbad Technology Inc. et al. (Federal District Court for the Eastern District of New York). Represented Carlsbad Technology Inc. and Andrx Pharmaceutical Co. against Richter Gideon Pharmaceutical Co. for patent infringement, which involved famotidine. (2003-2004)
ITC Section 337 Investigation: Certain Ground Fault Circuit Interrupters and Components Thereof. Represented Wenzhou Van-Sheen Electric Appliance Co. and Yueqing Hwameli Electric Inc. of China against Leviton Manufacturing Co. (2002-2003)
ITC Section 337 Investigation: Certain Agricultural Vehicles and Tractors Thereof. Represented Jiangling Motor Inc. and Dongfeng Tractor Group of China against John Deere Co. (2003)
ITC Section 337 Investigation: Certain Zero Mercury Alkaline Battery and Components Thereof. Represented Chung Pak Battery Group of Hong Kong against Everready Holding Co. (2003-2004)
Leader Technology Co. v. MultiNational Resources Co. (State Court of New Hampshire at Concord and AAA Abritration). Represented Leader Technology Co. of Taiwan to sue MultiNational Resources Co. for non-payment of fees. (2003-2005)
Shanghai Meihao Electric Inc. v. Leviton Manufacturing Co. (Federal District Court for the District of Maryland at Baltimore). Represented Shanghai Meihao Electric Inc. against Leviton Manufacturing Co. for patent infringement, which involved ground fault circuit interrupters. (2003-2006)
Peter Chee-Keung Chung v. Xin Liu (Federal District Court for the District of Columbia). Represented Peter Chee-Keung Chung to sue Xin Liu for misjoinder of inventorship. (2004-2005)
PTO Interference: Peter Chee-Keung Chung v. Xin Liu. Represented Peter Chee-Keung Chung before the Board of Patent Appeals and Interference at the US Patent and Trademark Office. (2005)
ITC Section 337 Investigation: Certain Color TVs and Computer Monitors and Components Thereof. Represented BenQ Corp., BenQ America Corp. and AU Optronics of Taiwan against Thomson Licensing SA and Thomson Licensing Inc. (2005)
ITC Section 337 Investigation: Certain CD and DVD Players and Components Thereof. Represented BenQ Corp. and BenQ America Corp. of Taiwan against Thomson Electric Co. (2005)
Plantex USA v. Carlsbad Technology Inc. (Federal District Court for the Southern District of California). Represented Carlsbad Technology Inc. against Plantex USA for violation of a memorandum of understanding agreement.
ARTICLES / PUBLICATIONS
The importance of obtaining opinion of counsel in patent infringement dispute, Pharmaceutical Industrial Technology Research Center, Taipei, Taiwan (2002)
Apolipoprotein B stimulates formation of monocytemacrophage surface-connected compartments and mediates uptake of low density lipoprotein-derived liposomes into these compartments, (with H.S. Kruth, W.-Y. Zhang and S.I. Skarlatos), J. Biol. Chem. (1999)
Conflicts in Wetlands Regulation: Do We Have a Resolution? The 12th R. Marlin Smith Student Writing Contest, American Planning Association, American Bar Association (1995)
Power Line Electromagnetic Fields Controversy: How to Cope with Scientific Uncertainty? The 1994 Roscoe Hogan Environmental Law Essay Contest (1994)
High density lipoproteins fail to completely solubilize cholesterol-rich liposomes from human atherosclerotic lesions, (with E.J. Blanchette-Mackie, L.M. Amende, N. Rifai and H.S. Kruth), J. Lipid Res. (1996)
The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and Jurkat cell lines, (with N. Rifai, Q. Pham, J. Thiessen and S. Soldin), Clin. Biochem. (1996)
Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis, (with D.N. Mukhin and H.S. Kruth), Arteriosclerosis, Thrombosis and Vascular Biology (1995)
Development of unesterified cholesterol-rich lipid particles in atherosclerotic lesions of WHHL and cholesterol-fed NZW rabbits, (with E.J. Blanchette-Mackie, B.F. Dickens, Y.-J. Chen, Y.-S. Li, W. Gamble and H.S. Kruth), J. Lipid (1994)
Hydrolysis of Cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome, (with E.J. Blanchette-Mackie, V.V. Tertov, S.I. Skarlatos, Y.-J. Chen and H.S. Kruth), J. Biol. Chem. (1992)
In vitro solubilization of aortic unesterified cholesterol-rich lipid particles by high density lipoproteins, (with N. Rifai, E.J. Blanchette-Mackie and H.S. Kruth), Clin. Chem. (1991)
Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions, (with E.J. Blanchette-Mackie, Y.-J. Chen, B.F. Dickens, E. Berlin, L.M. Amende, S.I. Skarlatos, W. Gamble, J.H. Resau, W.T. Mergner and H.S. Kruth), Amer. J. Pathol. (1990)
Isolation and characterization of cholesterol-containing particles released from thrombin activated rat and human blood platelets, (with S.I. Skarlatos, L.M. Amende, E.J. Blanchette-Mackie, W. Gamble and H.S. Kruth), Lab. Invest. (1988)
Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas, (with L.M. Amende, E.J. Blanchette-Mackie, S.I. Skarlatos, W. Gamble, J.H. Resau, W.T. Mergner and H.S. Kruth), Amer. J. Pathol. (1988)
Hepatocellular triglyceride synthesis and transfer to lipid droplets and nascent very-low-density lipoproteins, (with D.L. Stiers and J.A. Ontko), J. Lipid Res. (1986)
Regulation of hepatic triglyceride storage and secretion,Ph.D. Dissertation, University of Oklahoma, Oklahoma City, OK (1985)
Contribution of fatty acid and sterol synthesis to triglyceride and cholesterol secretion by the perfused rat liver in genetic hyperlipemia and obesity, (with M.J. Azain, N. Fukuda, M. Yamamoto and J.A. Ontko), J. Biol. Chem. (1985)
Isolation and partial characterization of restriction endonucleases from Xanthomonas Oryzae, M.S. Thesis, National Chung Hsing University, Taichung, Taiwan (1979)
Abstracts
Development of unesterified cholesterol-rich lipid particles in atherosclerotic lesions of cholesterol-fed rabbits, (with E.J. Blanchette-Mackie, B.F. Dickens, Y.-J. Chen, W. Gamble and H.S. Kruth), Amer. J. Physiol. (1990)
Possible mechanism of platelet-mediated cholesterol accumulation, (with S.I. Skarlatos, R. Rao and H.S. Kruth), Fed. Proc. (1989)
Characterization of extracellular cholesterol-rich particles in human atherosclerotic lesions, (with E.J. Blanchette-Mackie, B.F. Dickens, E. Berlin, S.I. Skarlatos, Y.-J. Chen, J.H. Resau, L.M. Amende, W.T. Mergner and H.S. Kruth), Fed. Proc. (1989)
Biochemical and ultrastructural characterization of cholesterol-phospholipid-containing particles released from activated platelets, (with S.I. Skarlatos, L.M. Amende, E.J. Blanchette-Mackie, W. Gamble, R. Rao and H.S. Kruth), Arteriosclerosis (1988)
Characterization of two novel types of cholesterol-rich lipid particles isolated from human atherosclerotic lesions, (with E.J. Blanchette-Mackie, B.F. Dickens, E. Berlin, L.M. Amende, S.I. Skarlatos, Y.-J. Chen and H.S. Kruth), Arteriosclerosis (1988)
Biochemical and ultrastructural characterization of cholesterol-containing particles released from activated rat and human platelets, (with S.I. Skarlatos, L.M. Amende, E.J. Blanchette-Mackie, W. Gamble and H.S. Kruth), 8th International Symposium on Atherosclerosis (1988)
Unesterified cholesterol-rich lipid particles in human atherosclerotic lesions, (with H.S. Kruth, Y.-J. Chen, L.M. Amende, E.J. Blanchette-Mackie, S.I. Skarlatos, B.F. Dickens, J.H. Reseau, W.T. Mergner and W. Gamble), 8th International Symposium on Atherosclerosis (1988)
Accumulation of unesterified cholesterol-rich multilamellar liposomes in human type C Niemann-Pick disease fibroblasts: A defective response to low density lipoprotein uptake, (with E.J. Blanchette-Mackie, S.I. Skarlatos, P.G. Pentchev, M.E. Comly and H.S. Kruth), 8th International Symposium on Atherosclerosis (1988)
Structural change of human LDL accompanying hydrolysis of cholesterol ester, (with L.M. Amende, E.J. Blanchette-Mackie, S.I. Skarlatos and H.S. Kruth), Fed. Proc. (1988)
Structure of human LDL after degradation of apoB and hydrolysis of cholesterol ester, (with L.M. Amende, S.I. Skarlatos, E.J. Blanchette-Mackie and H.S. Kruth), Arteriosclerosis (1987)
Isolation and characterization of cholesterol-containing particles released from thrombin-activated human blood platelets, (with S.I. Skarlatos, W. Gamble and H.S. Kruth), Fed. Proc. (1987)
Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas, (with L.M. Amende, E.J. Blanchette-Mackie, S.I. Skarlators and H.S. Kruth), Fed. Proc. (1987)
Unesterified cholesterol-rich lipid particles in aortas of cholesterol-rich lipid particles in aortas of cholesterol-fed rabbits and rats, (with H.S. Kruth), Vith International Washington Spring Symposium Cardiovascular Disease ’86 (1986)
Deposition of triglyceride in distinct hepatocellular compartments, (with D.L. Stiers and J.A. Ontko), Fed. Proc. (1985)
BRIEFINGS, SEMINARS & SPEECHES
Experimental Use Exception after Merck v. Integra, National Health Research Institute, Taipei, Taiwan (December 2005)
New Trends in ANDA Litigations, Pharmaceutical Industry Technology Development Center, Taipei, Taiwan (December 2005)
A Patent Attorney’s Role in Protecting Client’s Intellectual Property, Industrial Technology Research Institute, Hsinchu, Taiwan (June 2004)
Protection of Biotechnological Inventions in the U.S., Biomedical Institute of Industrial Technology Research Institute, Hsinchu, Taiwan (October 2003)
Deposit of Biological Materials for Patents, Food Industry Technology Center, Hsinchu, Taiwan (October 2003)
Patent Portfolios in Conjunction with FDA Regulation in the U.S., Pharmaceutical Industrial Technology Development Center, Taipei, Taiwan (October 2003)
Chinese Herbal Medicines: Intellectual Property Protection, Ministry of Economic Affairs, Taipei, Taiwan (October 2003)
Pharmaceutical Patents: Infringement Litigation Strategies and Case Analysis, Pharmaceutical Industrial Technology Development Center, Taipei, Taiwan (October 2003)
"Section 337 Investigations at the International Trade Commission, Chinese Battery Association Meeting, Ningbo, China (May 2003)
"Strategies and Winning Section 337 Investigations at the International Trade Commission," China Chamber of Commerce, Beijing, China (December 2002)
PROFESSIONAL / CIVIC AFFILIATIONS
Mid-Atlantic Lipid Society
American Chemical Society
American Intellectual Property Law Association
American Bar Association
ITC Trial Lawyers Association
|
